Recent advances in targeting mTOR signaling pathway using small molecule inhibitors-Reference-Cited by-同舟云学术

Recent advances in targeting mTOR signaling pathway using small molecule inhibitors

Published:2016-10-03 Issue:3 Volume:25 Page:189-201
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Roohi Azam¹,Hojjat-Farsangi Mohammad²³

Affiliation:

1. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran;

2. Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden;

3. Department of Immunology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2016.1236112

Reference157 articles.

1. A Year in Structural Signaling: mTOR—The PIKK of the Bunch?

2. Current development of mTOR inhibitors as anticancer agents

3. The mTOR Signalling Pathway in Human Cancer

4. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

5. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC and non-small cell lung cancer: A comprehensive review;Human Gene;2023-09

2. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma;Current Medicinal Chemistry;2021-05-31

3. MYC inhibitors in multiple myeloma;Cancer Drug Resistance;2021

4. Harnessing WYE-132 as an inhibitor of the mTOR signaling enriches the cytotoxicity effect of vinblastine in B16F10 melanoma cancer cells;Process Biochemistry;2020-12

5. Upregulation of Akt/Raptor signaling is associated with rapamycin resistance of breast cancer cells;Chemico-Biological Interactions;2020-10